healthcare
Tpg in Talks to Buy UnitedHealth's Optum UK Unit, Sky News Reports
Nestle Recalls Infant Formula Batches in 25 Countries Over Toxin Risk
Exclusive-Novo Nordisk's US Public Affairs Head Leaves Company, Memo Shows
UK's Pharma Regulator Could Issue a Decision for Novo's Wegovy Pill by Year-End
Novo Launches Wegovy Weight-Loss Pill for Sale in US
Date: January 5, 2026
COPENHAGEN, Jan 5 (Reuters) - Denmark's Novo Nordisk will offer its 1.5 and 4 milligram Wegovy weightloss pills at $149 per month to self-paying patients in the United States from January 5, it said...
Novo and Lilly Cut Prices of Weight-Loss Drugs in China
Date: December 29, 2025
Dec 29 (Reuters) - Danish drugmaker Novo Nordisk has nearly halved prices of its obesity drug Wegovy in some Chinese provinces, local media Yicai reported on Monday. The list prices for the two...
Lilly, Novo Lock Horns in India's Obesity Drug Race
Date: December 24, 2025
HYDERABAD, India, Dec 24 (Reuters) - Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market before cheaper generic versions hit...
Biathlon-Norway's Botn Turns to Bjoerndalen for Help Dealing With 'ugly' Medical Condition
Date: December 23, 2025
Dec 23 (Reuters) - Norwegian biathlete Johan-Olav Botn is looking to follow in the footsteps of his compatriot and eight-times Olympic champion Ole Einar Bjoerndalen and will seek his advice in...
Factbox-Weight-loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up
Date: December 23, 2025
Dec 23 (Reuters) - The weight-loss drug market is surging, with biotech firms racing to win share in a sector dominated by Novo Nordisk and Eli Lilly. Analysts forecast the industry will generate...
Novo Nordisk Shares Jump After US Approves Wegovy Pill
Date: December 23, 2025
Dec 23 (Reuters) - Novo Nordisk's Frankfurt-listed shares opened nearly 10% higher in early trading on Tuesday after the U.S. Food and Drug Administration approved its weight-loss pill. The move gives...
